Presumptive adult TB
Showing 1 - 25 of >10,000
Next Generation LAM Assays and Molecular Diagnostics for
Not yet recruiting
- Tuberculosis
- (no location specified)
Aug 24, 2023
Tuberculosis Trial in Uganda (SMS, Phone call, Mobile money incentive)
Not yet recruiting
- Tuberculosis
- SMS
- +2 more
-
Luwero, Kasana, Uganda
- +4 more
Jul 19, 2023
Tuberculosis, Diagnoses Disease Trial (Truenat TB platform/TB assays)
Recruiting
- Tuberculosis
- Diagnoses Disease
- Truenat TB platform/TB assays
-
Manhiça, Vila Da Manhiça, Mozambique
- +3 more
Nov 30, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg
Recruiting
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +3 more
-
Johannesburg, South Africa
- +2 more
Oct 4, 2021
Tuberculosis Trial in Bissau, Malakal
Recruiting
- Tuberculosis
-
Bissau, Guinea-Bissau
- +1 more
Aug 23, 2022
Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)
Not yet recruiting
- Tuberculosis
- Quantiferon Gold
- +5 more
- (no location specified)
Oct 27, 2023
Truenat™MTB Plus/COVID-19 Test for TB and COVID-19
Not yet recruiting
- TB
- COVID-19
- Truenat™ MTB Plus/COVID-19
- (no location specified)
Jun 10, 2022
Tuberculosis Trial in Cameroon, Uganda (Screening and initiating preventive therapy in communities)
Active, not recruiting
- Tuberculosis
- Screening and initiating preventive therapy in communities
-
Bonabéri, Cameroon
- +24 more
Jun 15, 2022
Start Taking Action For TB Diagnosis
Not yet recruiting
- Diagnosis
- Tuberculosis
- Molecular Diagnostics
- +4 more
- (no location specified)
Apr 25, 2023
Human Immunodeficiency Virus (HIV) Infection Trial in Maseru, Blantyre (ART first- Therapeutic use trial, TB results first-
Recruiting
- Human Immunodeficiency Virus (HIV) Infection
- ART first- Therapeutic use trial
- TB results first- Therapeutic use trial
-
Maseru, Lesotho
- +1 more
Aug 10, 2022
Tuberculosis Trial in Klaten, Yogyakarta (exhaled breath sampling)
Recruiting
- Tuberculosis
- exhaled breath sampling
-
Klaten, Central Java, Indonesia
- +1 more
Mar 27, 2022
Tuberculosis, Respiratory Tract Infections, Pneumonia Trial in Blantyre (Azithromycin, Amoxicillin)
Completed
- Tuberculosis
- +2 more
-
Blantyre, Southern, MalawiUniversity of Malawi College of Medicine
Apr 26, 2021
Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +5 more
-
Minsk, Belarus
- +6 more
May 12, 2021
Tuberculosis, Pulmonary Trial in Mbeya (N-acetyl cysteine)
Recruiting
- Tuberculosis, Pulmonary
- N-acetyl cysteine
-
Mbeya, TanzaniaNIMR-Mbeya Medical Research Centre
Jan 18, 2021
Tuberculosis, HIV Trial in Worldwide (External validation of the PAANTHER TB treatment decision algorithm)
Recruiting
- Tuberculosis
- HIV
- External validation of the PAANTHER TB treatment decision algorithm
-
Abidjan, Côte D'Ivoire
- +6 more
Sep 15, 2021
Tuberculosis Trial in Abuja, Dasmariñas, Lusaka (Tongue swab-based molecular assays)
Not yet recruiting
- Tuberculosis
- Tongue swab-based molecular assays
-
Abuja, Nigeria
- +2 more
Jul 11, 2023
Tuberculosis, Pediatric Trial in Worldwide (Innovative approached to pediatric TB care)
Completed
- Tuberculosis
- Pediatric
- Innovative approached to pediatric TB care
-
Djoungolo, Cameroon
- +9 more
Jul 21, 2022
Host Blood RNA Signatures for Diagnosis of TB (RADIANT)
Recruiting
- Tuberculosis
- NanoString nCounter assay
-
Cape Town, Western Cape, South Africa
- +1 more
Sep 12, 2022
Tuberculosis Trial in Phnom Penh (ACF with a seed-and-recruit model, ACF targeting household and neighborhood contacts, ACF
Completed
- Tuberculosis
- ACF with a seed-and-recruit model
- +3 more
-
Phnom Penh, Cambodia
- +2 more
Nov 26, 2022
HIV Trial (GEO-D02 DNA, MVA/HIV62B Vaccine, B63521^11 gp120)
Withdrawn
- HIV Infections
- GEO-D02 DNA
- +4 more
- (no location specified)
Oct 13, 2021
Tuberculosis, Children, Only, Diagnosis Trial in Cameroon, Kenya (Integrated pediatric TB services)
Completed
- Tuberculosis
- +3 more
- Integrated pediatric TB services
-
Akonolinga, Centre, Cameroon
- +11 more
Mar 22, 2022
Mycobacterium Tuberculosis, Protection Against, Tuberculosis Trial in Lausanne (ChadOx1 85A - aerosol, ChadOx1 85A - IM)
Completed
- Mycobacterium Tuberculosis, Protection Against
- Tuberculosis
- ChadOx1 85A - aerosol
- ChadOx1 85A - IM
-
Lausanne, SwitzerlandCentre hospitalier universitaire vaudois
Sep 24, 2020